Transfusion transmission of vCJD: A crisis avoided?

Lancet

Volumn 364, Issue 9433, 2004, Pages 477-479

  Wilson, Kumanan ^a   Ricketts, Maura N ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; AUTOPSY; BIOACCUMULATION; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; DNA MODIFICATION; HEALTH CARE POLICY; HEPATITIS C; HETEROZYGOSITY; HUMAN; MALARIA CONTROL; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL; RISK FACTOR; TRANSFUSION;

EID: 4043126671     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16820-7     Document Type: Note

References (22)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925
2. Further precautionary measures on blood products announced. Department of Health press release on CJD/BSE (United Kingdom 98/076). Feb 26, 1998.
3. Government accepts advice on leucodepletion from Spongiform Encephalopathy Advisory Committee. Department of Health press release (United Kingdom 98/295). July 17, 1998.
4. Guidance for Industry. Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products. US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Jan, 2002: http://www.fda.gov/cber/gdlns/ cjdvcjd.pdf (accessed July 28, 2004).
5. Boulton F. The impact of variant CJD on transfusion practices in the UK. Transfus Apheresis Sci. 28:2003;107-116
6. The vCJD Working Party of the Standing Advisory Committee on Transfusion Transmitted Infections. Creutzfeldt-Jakob disease. Joint UKBTS/NIBSC Position Statements, April, 2004: http://www.transfusionguidelines.org.uk/docs/pdfs/ position_statement_01_2004_04.pdf (accessed July 16, 2004).
7. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet. 349:1997;99-100
8. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J. Species-barrier independent prion replication in apparently resistant species. Proc Natl Acad Sci USA. 97:2000;10248-10253
9. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of SE by blood transfusion in sheep. Lancet. 356:2000;999-1000
10. Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol. 83:2002;2897-2905
11. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 363:2004;422-428
12. Herzog C, Sales N, Etchegaray N, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet. 363:2004;422-428
13. Brown P, Rohwer RG, Dunstan BC, et al. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion. 38:1998;810-816
14. Flanagan P, Barbara JA. Prion disease and blood. Transfus Med. 6:1996;213-215
15. Wilson K, Wilson M, Graham I, Hebert P. The application of the precautionary principle to the health sector: lessons learned from decisions concerning variant Creutzfeldt-Jakob disease and the blood supply. Transfus Med Rev. 17:2003;89-94
16. Roberts DR, Manguin S, Mouchet J. DDT house spraying and re-emerging malaria. Lancet. 356:2000;330-332
17. Masood E. A continent divided. Nature. 426:2003;224-226
18. Hebert PC, Fergusson D, Blajchman MA, for the Leukoreduction Study Investigators. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289: 1941-1949.
19. Brown P. Environmental causes of human spongiform encephalopathy. Baker H, Ridley RM. Methods in molecular medicine: prion diseases. 1996;139-154 Humana Press Inc, Totowa, NJ
20. Mayor S. UK government advises tighter measures to reduce risk of CJD transmission during neurosurgery. BMJ. 326:2003;517-518
21. Kirkup B. Incident arising in October 2002 from a patient with CJD in Middlesbrough: report of incident review. DOH publication 28/02/2003: http://www.dh.gov.uk/assetRoot/04/06/08/73/04060873.pdf (accessed July 16, 2004).
22. Frosh I, Joyce R, Johnson A. Iatrogenic vCJD from surgical instruments. BMJ. 322:2001;1558-1559